Literature DB >> 8550676

Association of antithrombotic factor deficiencies and hypofibrinolysis with Legg-Perthes disease.

C J Glueck1, A Crawford, D Roy, R Freiberg, H Glueck, D Stroop.   

Abstract

Thirty-three (75 per cent) of forty-four unselected children who had Legg-Perthes disease were found to have coagulation abnormalities. Twenty-three children had thrombophilia (a deficiency in antithrombotic factor C or S, with an increased tendency toward thrombosis); nineteen of the twenty-three children had protein-C deficiency and four had protein-S deficiency. Seven children had a high level (0.25 gram per liter or more) of lipoprotein(a), a thrombogenic, atherogenic lipoprotein associated with osteonecrosis in adults. Three children had hypofibrinolysis (a reduced ability to lyse clots). The mean age of the children when the Legg-Perthes disease was first diagnosed was 5.8 +/- 2.7 years, and the mean age at the time of the present study was 10.1 +/- 4.4 years. At least one of the first-degree relatives of eleven of the nineteen probands who had a low protein-C level had a low protein-C level as well; all of these low levels represented previously undiagnosed familial protein-C deficiency. The eleven probands who had familial protein-C deficiency were more likely to have early onset of Legg-Perthes disease (at or before the age of five years) than the eleven children who had normal levels of protein C, protein S, and lipoprotein(a) as well as normal fibrinolytic activity (chi-square = 6.6; p = 0.01). At least one first-degree relative of one of the four probands who had a low protein-S level had a low protein-S level and previously undiagnosed familial protein-S deficiency. At least one first-degree relative of six of the seven probands who had a high level of lipoprotein(a) had a familial high level of lipoprotein(a). Six of the seven children who had a high level of lipoprotein(a) also had a low level of stimulated tissue-plasminogen activator activity, the major initiator of fibrinolysis. At least one first-degree relative of one of the three probands who had normal levels of protein C, protein S, and lipoprotein(a) but low stimulated tissue-plasminogen activator activity also had low stimulated tissue-plasminogen activator activity (familial hypofibrinolysis). Legg-Perthes disease, thrombophlebitis, premature myocardial infarction, and stroke, which are ramifications of the familial thrombophilic-hypofibrinolytic disorders, were common in the first and second-degree relatives of the thirty-three children with Legg-Perthes disease who also had thrombophilic-hypofibrinolytic disorders.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8550676     DOI: 10.2106/00004623-199601000-00002

Source DB:  PubMed          Journal:  J Bone Joint Surg Am        ISSN: 0021-9355            Impact factor:   5.284


  9 in total

1.  Biphasic threat to femoral head perfusion in abduction: arterial hypoperfusion and venous congestion.

Authors:  David K Yousefzadeh; Diego Jaramillo; Neil Johnson; Kirk Doerger; Christopher Sullivan
Journal:  Pediatr Radiol       Date:  2010-05-07

2.  A recurrent mutation in type II collagen gene causes Legg-Calvé-Perthes disease in a Japanese family.

Authors:  Yoshinari Miyamoto; Tatsuo Matsuda; Hiroshi Kitoh; Nobuhiko Haga; Hirofumi Ohashi; Gen Nishimura; Shiro Ikegawa
Journal:  Hum Genet       Date:  2007-03-30       Impact factor: 4.132

3.  The incidence and distribution of Legg-Calvé-Perthes' disease in Liverpool, 1982-95.

Authors:  B M Margetts; C A Perry; J F Taylor; P H Dangerfield
Journal:  Arch Dis Child       Date:  2001-04       Impact factor: 3.791

4.  Heritable thrombophilia-hypofibrinolysis and osteonecrosis of the femoral head.

Authors:  Charles J Glueck; Richard A Freiberg; Ping Wang
Journal:  Clin Orthop Relat Res       Date:  2008-03-19       Impact factor: 4.176

5.  Autosomal dominant avascular necrosis of femoral head in two Taiwanese pedigrees and linkage to chromosome 12q13.

Authors:  Wei-Ming Chen; Yu-Fen Liu; Ming-Wei Lin; I-Chun Chen; Pei-Yu Lin; Guan-Lu Lin; Yuh-Shan Jou; Yang-Te Lin; Cathy S J Fann; Jer-Yuarn Wu; Kwang-Jen Hsiao; Shih-Feng Tsai
Journal:  Am J Hum Genet       Date:  2004-06-03       Impact factor: 11.025

Review 6.  Orthopedic involvement in antiphospholipid syndrome.

Authors:  Alexander Gorshtein; Yair Levy
Journal:  Clin Rev Allergy Immunol       Date:  2007-04       Impact factor: 8.667

7.  The time of the insult/triggering event in Legg-Calvé-Perthes' disease determined by incubation period modeling and the age distribution of children with Perthes'.

Authors:  Randall T Loder; Richard H Browne; Andrew Millis; Wook-Cheol Kim; Hitesh Shah; Aidan P Cosgrove; Ola Wiig
Journal:  Iowa Orthop J       Date:  2012

8.  Local Delivery of Single Dose Intra Epiphyseal Bisphosphonates to Prevent the Progression of Legg-Calve-Perthes Disease - Case Series.

Authors:  R Sivakumar; V Somashekar; Prahalad Kumar Singhi; M Chidambaram
Journal:  J Orthop Case Rep       Date:  2020 Aug-Sep

Review 9.  The epidemiology and demographics of legg-calvé-perthes' disease.

Authors:  Randall T Loder; Elaine N Skopelja
Journal:  ISRN Orthop       Date:  2011-09-05
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.